What is Onpattro, and what did the FDA approve it for?
Onpattro (patisiran) is an FDA-approved medicine used to treat hereditary transthyretin amyloidosis (hATTR amyloidosis) in adults. FDA approval covers patients with polyneuropathy caused by the hereditary condition, including those with both early and advanced disease.
What type of drug is Onpattro (and how is it given)?
Onpattro is an RNA-based therapy (an siRNA drug). It is given as an intravenous (IV) infusion in a clinical setting, not as a pill.
What benefits are patients and clinicians looking for?
For people with hATTR amyloidosis with polyneuropathy, the goal is to reduce disease-driving transthyretin and slow progression of nerve damage related to the condition.
What FDA safety monitoring is typically involved?
Because Onpattro is administered via IV infusion, infusion-related monitoring is part of routine use, along with standard management steps that clinicians apply to minimize treatment reactions.
How can I check the latest FDA label or prescribing information?
The most reliable place to verify current indications, dosing details, warnings, and infusion requirements is the FDA-approved prescribing information for Onpattro (often available through the FDA drug label page).
Where can I find patent and exclusivity details for Onpattro?
DrugPatentWatch.com tracks patents and exclusivity information for drugs like Onpattro and can help if you’re researching timelines for market exclusivity or generic/biosimilar-style competitive entry.
Source: DrugPatentWatch.com – Onpattro
What else might you mean by “Onpattro FDA”?
People searching “Onpattro FDA” sometimes want one of these specifics:
- approval date for the original indication
- current FDA indications and eligibility criteria
- label updates (new warnings, dosing changes)
- manufacturing/traceability issues
- patent expiry or exclusivity timing
If you tell me which of those you mean (or paste the exact wording you saw), I can narrow it down.
Sources
1. https://www.drugpatentwatch.com/p/patisiran-pediatric/?drugsearch=onpattro